These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2844208

  • 1. Effects of prostacyclin analogs on cyclic adenosine monophosphate and superoxide formation in human polymorphonuclear leukocytes stimulated by formyl-methionyl-leucyl-phenylalanine.
    Stahlberg HJ, Loschen G, Flohé L.
    Biol Chem Hoppe Seyler; 1988 May; 369(5):329-36. PubMed ID: 2844208
    [Abstract] [Full Text] [Related]

  • 2. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
    Armstrong RA.
    Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
    [Abstract] [Full Text] [Related]

  • 3. The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine.
    Gryglewski RJ, Szczeklik A, Wandzilak M.
    Biochem Pharmacol; 1987 Dec 15; 36(24):4209-13. PubMed ID: 2446631
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2.
    Hecker G, Ney P, Schrör K.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr 15; 341(4):308-15. PubMed ID: 2159112
    [Abstract] [Full Text] [Related]

  • 5. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
    Fantone JC, Marasco WA, Elgas LJ, Ward PA.
    Am J Pathol; 1984 Apr 15; 115(1):9-16. PubMed ID: 6324595
    [Abstract] [Full Text] [Related]

  • 6. Inhibition by prostacyclin analogs of .O2- production in human polymorphonuclear leukocytes.
    Stahlberg HJ, Loschen G, Flohé L.
    Basic Life Sci; 1988 Apr 15; 49():991-5. PubMed ID: 2855018
    [No Abstract] [Full Text] [Related]

  • 7. Adrenergic modulation of human polymorphonuclear leukocyte activation. Potentiating effect of adenosine.
    Bazzoni G, Dejana E, Del Maschio A.
    Blood; 1991 May 01; 77(9):2042-8. PubMed ID: 1850310
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils.
    Talpain E, Armstrong RA, Coleman RA, Vardey CJ.
    Br J Pharmacol; 1995 Apr 01; 114(7):1459-65. PubMed ID: 7606349
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of circulating and exudated polymorphonuclear leukocytes in superoxide-generating response to cyclic AMP and cyclic AMP-elevating agents. Investigation of the underlying mechanism.
    al-Essa LY, Niwa M, Kohno K, Nozaki M, Tsurumi K.
    Biochem Pharmacol; 1995 Jan 31; 49(3):315-22. PubMed ID: 7857318
    [Abstract] [Full Text] [Related]

  • 10. Effect of colforsin on human neutrophil superoxide production and intracellular calcium mobilization.
    Furui H, Suzuki K, Takagi K, Satake T.
    Clin Exp Pharmacol Physiol; 1989 Mar 31; 16(3):199-209. PubMed ID: 2541955
    [Abstract] [Full Text] [Related]

  • 11. PGD2 and its mimetic ZK 110.841 are potent inhibitors of receptor-mediated activation of human neutrophils.
    Ney P, Schrör K.
    Eicosanoids; 1991 Mar 31; 4(1):21-8. PubMed ID: 1647806
    [Abstract] [Full Text] [Related]

  • 12. Stimulus-dependent inhibition of superoxide generation by prostaglandins.
    Sedgwick JB, Berube ML, Zurier RB.
    Clin Immunol Immunopathol; 1985 Feb 31; 34(2):205-15. PubMed ID: 2981649
    [Abstract] [Full Text] [Related]

  • 13. The inhibitory effects of non-prostanoid prostacyclin mimetics on rat neutrophil function.
    Wise H.
    Prostaglandins Leukot Essent Fatty Acids; 1996 May 31; 54(5):351-60. PubMed ID: 8832764
    [Abstract] [Full Text] [Related]

  • 14. Dopamine inhibition of superoxide anion production by polymorphonuclear leukocytes.
    Yamazaki M, Matsuoka T, Yasui K, Komiyama A, Akabane T.
    J Allergy Clin Immunol; 1989 May 31; 83(5):967-72. PubMed ID: 2541191
    [Abstract] [Full Text] [Related]

  • 15. Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes.
    Kainoh M, Imai R, Umetsu T, Hattori M, Nishio S.
    Biochem Pharmacol; 1990 Feb 01; 39(3):477-84. PubMed ID: 2154985
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils.
    Fantone JC, Kinnes DA.
    Biochem Biophys Res Commun; 1983 Jun 15; 113(2):506-12. PubMed ID: 6307290
    [Abstract] [Full Text] [Related]

  • 17. Involvement of cyclic AMP generation in the inhibition of respiratory burst by 2-phenyl-4-quinolone (YT-1) in rat neutrophils.
    Wang JP, Raung SL, Huang LJ, Kuo SC.
    Biochem Pharmacol; 1998 Dec 01; 56(11):1505-14. PubMed ID: 9827585
    [Abstract] [Full Text] [Related]

  • 18. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes.
    Schröder H, Ney P, Woditsch I, Schrör K.
    Eur J Pharmacol; 1990 Jul 03; 182(2):211-8. PubMed ID: 1697805
    [Abstract] [Full Text] [Related]

  • 19. Leukotriene formation by human polymorphonuclear leukocytes from endogenous arachidonate. Physiological triggers and modulation by prostanoids.
    Haurand M, Flohé L.
    Biochem Pharmacol; 1989 Jul 01; 38(13):2129-37. PubMed ID: 2735951
    [Abstract] [Full Text] [Related]

  • 20. Inhibitory effects of sulfasalazine and related compounds on superoxide production by human polymorphonuclear leukocytes.
    Carlin G, Djursäter R, Smedegård G.
    Pharmacol Toxicol; 1989 Aug 01; 65(2):121-7. PubMed ID: 2573051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.